ArticleScientific reports2025
Characteristics of quinolone resistance in Escherichia coli isolated from wildlife in Poland.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High clonal diversity, resistome, and virulome ofFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The widespread use of quinolones (QNs) in human and veterinary medicine has resulted in the emergence of QN-resistant bacteria. The most common and widespread type of resistance to FQ is the presence of point mutations in the QRDR region and/or PMQR genes. The aim of the study was to analyze the mechanisms of quinolone resistance among E. coli strains isolated from wild animals in Poland. Out of 42 tested isolates, 39 strains had at least one point mutation in the gyrA gene; however, 76.2% of the isolates had at least three mutations in the GyrA and ParC domains, mainly S83L or D87L in the gyrA gene and S80I in the parC gene. Single isolates had also other mutations: D87Y in the GyrA domain and E84G, A108V, G78C, or S80R in the ParC domain. In 12 strains (28.5%), including three in which no QRDR mutations were confirmed, the presence of single PMQR genes: qnrB, qnrS, and aac(6')-Ib-cr was also demonstrated. Accumulation of point mutations was associated with high values of MIC of fluoroquinolones and single mutations or the presence of PMQR genes were associated with low-level resistance (MIC from 2 to 8 mg/L). The comparative method (MAS-PCR) confirmed the results of sequencing in most cases (90.5%). The E. coli strains isolated from the wildlife were characterized by the same mechanisms of QNs-resistance as those most often identified among isolates from anthropogenic environments. The obtained results indicate that the level of QNs-resistance is really high and monitoring should be obligatorily extended to the natural environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.